Description
Added on the 26/03/2021 05:33:04 - Copyright : Wochit
The Suzuki S-Cross has earned high acclaim for its stylish design, compact and easy to manage dimensions, good on-road performance as well as off-road capability with its optional ALLGRIP Select 4x4 system. It is now replaced by an all-new model which takes advantage of Suzuki’s long established expertise in packaging vehicles above their class with flexibility, an even higher level of safety equipment and the latest technology to meet the diverse needs of both driver and passengers. The S-Cross expresses Suzuki’s SUV styling heritage and the new model makes a strong statement featuring a bold and more muscular design that enhances its presence with larger and more angular wheel arches and smooth flowing lines. The front design incorporates a raised bonnet line, piano black front grille and new design three LED position headlamps that help portray a high centre of gravity. This theme continues at the rear with larger combination lamps that integrate horizontally with the rear centre garnish to emphasise a sense of width, in addition to roof rails and integrated rear spoiler. This all-new design is complemented with a more spacious and versatile interior and an even higher standard and safety specification than the previous model.S-Cross is produced at the Magyar Suzuki plant in Hungary which also produces Vitara models for European markets as well as exports of both vehicles around the world.
The Suzuki S-Cross has earned high acclaim for its stylish design, compact and easy to manage dimensions, good on-road performance as well as off-road capability with its optional ALLGRIP Select 4x4 system. It is now replaced by an all-new model which takes advantage of Suzuki’s long established expertise in packaging vehicles above their class with flexibility, an even higher level of safety equipment and the latest technology to meet the diverse needs of both driver and passengers. The S-Cross expresses Suzuki’s SUV styling heritage and the new model makes a strong statement featuring a bold and more muscular design that enhances its presence with larger and more angular wheel arches and smooth flowing lines. The front design incorporates a raised bonnet line, piano black front grille and new design three LED position headlamps that help portray a high centre of gravity. This theme continues at the rear with larger combination lamps that integrate horizontally with the rear centre garnish to emphasise a sense of width, in addition to roof rails and integrated rear spoiler. This all-new design is complemented with a more spacious and versatile interior and an even higher standard and safety specification than the previous model.S-Cross is produced at the Magyar Suzuki plant in Hungary which also produces Vitara models for European markets as well as exports of both vehicles around the world.
A new study has identified a link between stress hormones and the recurrence of cancer. UPI reports the findings may explain why cancers can return long after seemingly being cured with chemotherapy or surgery. The study showed stress hormones and immune cells called neutrophils may awaken dormant cancer cells and cause tumors to regrow -- even after treatment -- according to a study published Wednesday by Science Translational Medicine. Tumor recurrence may be facilitated by common stress. Study co-author Dr. Dmitry Gabrilovich Chief Scientist, AstraZeneca Stress hormones such as cortisol have been linked with an increased risk for a number of health problems. Elevated levels of these hormones can increase a person's heart rate and lead to rises in blood pressure. Because of this, it can lead to insomnia, robbing the body of needed sleep, and mental health disorders such as anxiety and depression.
A new study reveals a COVID-19 vaccine under development in England safely promotes an immune response against the virus. According to UPI, the vaccine is in Phase 2 of clinical trials with Astra Zeneca, and is particularly effective in elderly recipients who are over age 70. Researchers say the finding of the 'robust' responses in older people in their study is both significant and encouraging. The populations at greatest risk of serious COVID-19 disease include people with existing health conditions and older adults. The so-called "Oxford vaccine," formally known as ChAdOx1 nCoV-19, is one of more than 120 being evaluated in response to the COVID-19 pandemic. To date, 48 of these vaccines have gotten into clinical trials to assess their safety and efficacy.
|
Support : Technical 
- Content 
- Editors 
